Form 8-K - Current report:
SEC Accession No. 0000950170-23-026230
Filing Date
2023-06-05
Accepted
2023-06-05 07:06:58
Documents
48
Period of Report
2023-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-20230605.htm   iXBRL 8-K 57955
2 EX-99.1 eypt-ex99_1.htm EX-99.1 28932
3 EX-99.2 eypt-ex99_2.htm EX-99.2 25699
4 GRAPHIC img96707757_0.jpg GRAPHIC 5406
5 GRAPHIC eypt-ex99_2s1.jpg GRAPHIC 206850
6 GRAPHIC eypt-ex99_2s2.jpg GRAPHIC 988943
7 GRAPHIC eypt-ex99_2s3.jpg GRAPHIC 473969
8 GRAPHIC eypt-ex99_2s4.jpg GRAPHIC 349893
9 GRAPHIC eypt-ex99_2s5.jpg GRAPHIC 332518
10 GRAPHIC eypt-ex99_2s6.jpg GRAPHIC 387957
11 GRAPHIC eypt-ex99_2s7.jpg GRAPHIC 398140
12 GRAPHIC eypt-ex99_2s8.jpg GRAPHIC 359906
13 GRAPHIC eypt-ex99_2s9.jpg GRAPHIC 160897
14 GRAPHIC eypt-ex99_2s10.jpg GRAPHIC 363944
15 GRAPHIC eypt-ex99_2s11.jpg GRAPHIC 466558
16 GRAPHIC eypt-ex99_2s12.jpg GRAPHIC 372616
17 GRAPHIC eypt-ex99_2s13.jpg GRAPHIC 466828
18 GRAPHIC eypt-ex99_2s14.jpg GRAPHIC 511315
19 GRAPHIC eypt-ex99_2s15.jpg GRAPHIC 346373
20 GRAPHIC eypt-ex99_2s16.jpg GRAPHIC 222180
21 GRAPHIC eypt-ex99_2s17.jpg GRAPHIC 331490
22 GRAPHIC eypt-ex99_2s18.jpg GRAPHIC 365465
23 GRAPHIC eypt-ex99_2s19.jpg GRAPHIC 383416
24 GRAPHIC eypt-ex99_2s20.jpg GRAPHIC 401488
25 GRAPHIC eypt-ex99_2s21.jpg GRAPHIC 341831
26 GRAPHIC eypt-ex99_2s22.jpg GRAPHIC 154607
27 GRAPHIC eypt-ex99_2s23.jpg GRAPHIC 415680
28 GRAPHIC eypt-ex99_2s24.jpg GRAPHIC 378529
29 GRAPHIC eypt-ex99_2s25.jpg GRAPHIC 161806
30 GRAPHIC eypt-ex99_2s26.jpg GRAPHIC 423994
31 GRAPHIC eypt-ex99_2s27.jpg GRAPHIC 365433
32 GRAPHIC eypt-ex99_2s28.jpg GRAPHIC 194272
33 GRAPHIC eypt-ex99_2s29.jpg GRAPHIC 390128
34 GRAPHIC eypt-ex99_2s30.jpg GRAPHIC 407919
35 GRAPHIC eypt-ex99_2s31.jpg GRAPHIC 342804
36 GRAPHIC eypt-ex99_2s32.jpg GRAPHIC 356393
37 GRAPHIC eypt-ex99_2s33.jpg GRAPHIC 205390
  Complete submission text file 0000950170-23-026230.txt   16815194

Data Files

Seq Description Document Type Size
38 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eypt-20230605_lab.xml EX-101.LAB 12806
39 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eypt-20230605.xsd EX-101.SCH 2475
40 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eypt-20230605_pre.xml EX-101.PRE 9457
42 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20230605_htm.xml XML 4523
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 23991211
SIC: 3826 Laboratory Analytical Instruments